Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus
Abstract Background Deteriorated arterial function and high incidence of cardiovascular events characterise diabetes mellitus. Metformin and recent antidiabetic drugs, SGLT2 inhibitors, reduce cardiovascular events. We explored the possible effects of empagliflozin’s effect on top of metformin treat...
Main Authors: | Mojca Lunder, Miodrag Janić, Miha Japelj, Andrej Juretič, Andrej Janež, Mišo Šabovič |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12933-018-0797-6 |
Similar Items
-
Effect of metformin and empagliflozin on adiponectin and leptin levels in rat model of hypo- and hyperthyroidism
by: Desimira Mironova, et al.
Published: (2021-01-01) -
The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome
by: Zeeshan Javed, et al.
Published: (2020-06-01) -
Spotlight on empagliflozin/metformin fixed-dose combination for the treatment of type 2 diabetes: a systematic review
by: Kedia R, et al.
Published: (2016-09-01) -
Simultaneous quantification of empagliflozin, linagliptin and metformin hydrochloride in bulk and synthetic mixture by RP–LC method
by: Ishita M. Patel, et al.
Published: (2021-08-01) -
Options for empagliflozin in combination therapy in type 2 diabetes mellitus
by: Hershon KS
Published: (2016-05-01)